Skip to main content
Be The Investor
S&P 500
7,690.73+0.41%
After Hours7,694.96+0.05%
Nasdaq Composite
26,430.89+1.11%
After Hours26,377.53-0.20%
Dow Jones
51,966.03-0.07%
After Hours52,067.61+0.20%
Russell 2000
2,728.30+0.25%
After Hours2,728.70+0.01%
VIX
VIX
18.44-7.75%
Bitcoin
81,923.65+0.10%
Ethereum
2,406.40+0.06%
Solana
104.95+0.02%
Gold
4,162.70+0.06%
Silver
57.64+0.63%
Copper
6.569-0.10%
WTI Crude Oil
98.82+0.28%
US 10-Year Treasury Yield
5.136+0.75%
Home›Stocks›MRK
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ
MRK

Merck & Co., Inc.

MRK
NYSEUnited States flagUSReal-Time Price
$143.67USD
-2.28 (-1.56%)Today
$143.94+0.27 (+0.19%)After Hours7:59 PM ET
BTI Score
Near Future
63
Long Term
63
BTI Fair Market Cap
$254.98B
+41.24% vs fair
Hold

Merck & Co., Inc. (MRK) Valuation

Is Merck & Co., Inc. (MRK) overvalued or undervalued? BTI's fair-value estimate, DCF model and valuation multiples show the premium or discount to intrinsic worth.

Valuation Snapshot

P/E (TTM)
Trailing Price-to-Earnings
114.02
Forward P/E
Next 12 months estimate
—
PEG Ratio
P/E to Growth ratio
—
Price / Sales
Market cap vs. revenue
—
Price / Book
Market cap vs. book value
—
EV / EBITDA
Enterprise value multiple
—
Earnings Yield
Inverse of P/E
0.88%
Revenue Growth
Year-over-year
—

Valuation Risk

Merck & Co., Inc.'s valuation multiples are within a moderate range, suggesting the market is not pricing in excessive optimism. Investors should monitor growth execution relative to valuation.

Run Full Valuation Model
DCF, multiples, scenario analysis and AI fair value for MRK